A Novel Asymmetrical Anti-Her2/Cd3 Bispecific Antibody Exhibits Potent Cytotoxicity for HER2-positive Tumor Cells
Journal of Experimental and Clinical Cancer Research - United Kingdom
doi 10.1186/s13046-019-1354-1
Full Text
Open PDFAbstract
Available in full text
Date
August 14, 2019
Authors
Publisher
Springer Science and Business Media LLC